-
Sarepta Therapeutics' (SRPT) "Buy" Rating Reiterated at Needham & Company LLC
来源: Buzz FX / 07 11月 2024 08:26:16 America/Chicago
Sarepta Therapeutics' (SRPT) "Buy" Rating Reiterated at Needham & Company LLC Written by MarketBeat November 7, 2024 Share Link copied to clipboard. Sarepta Therapeutics ( NASDAQ:SRPT - Get Free Report ) 's stock had its "buy" rating reiter
Read more...